J&J Consumer Health Has Digital And Natural Drivers For ‘Above Market’ Growth

摘要

An emphasis Johnson & Johnson made at the start of 2018 on growing digital sales and a mid-year move into the natural supplements category were key drivers for its 3.2% consumer health sales growth for the year. OTC drugs including Tylenol and Motrin analgesics, the Neu- trogena and OGX beauty lines and the Listerine oral care brand drove J&J’s consumer health sales were $13.9bn, a 1.8% increase accounting for the impact of currency exchange and acquisitions and divestitures, the frm reported Jan. 22.